WHO ICTRP trial

Clinical study for the safety and efficacy of short-course glucocorticoid…

ChiCTR1900027747 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR1900027747
Public title Clinical study for the safety and efficacy of short-course glucocorticoid therapy in newly diagnosed patients with primary immune thrombocytopenia who are effective with initial hormone therapy
Scientific title Clinical study for the safety and efficacy of short-course glucocorticoid therapy in newly diagnosed patients with primary immune thrombocytopenia who are effective with initial hormone therapy
Primary sponsor Department of Hematology, the Second Affiliated Hospital of Kunming Medical University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Observational study
Countries China
Conditions Primary Immune Thrombocytopenia
Interventions Short-course glucocorticoid group:Glucocorticoid decreased within 1 week;Routine glucocorticoids group:Glucocorticoid doses gradually decrease;Short-course low dose glucocorticoid maintenance group:Small doses of glucocorticoids maintained
Registration date Nov 25, 2019
Target size Short-course glucocorticoid group:65;Routine glucocorticoids…
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations